US Patent Issued to Ascensia Diabetes Care Holdings on Sept. 30 for "Automatic activation of continuous glucose monitoring (CGM) transmitter" (New York Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,431,727, issued on Sept. 30, was assigned to Ascensia Diabetes Care Holdings AG (Basel, Switzerland).

"Automatic activation of continuous glucose monitoring (CGM) transmitter" was invented by Igor Y. Gofman (Croton-on-Hudson, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A battery-operated electronic device, such as, e.g., a continuous glucose monitoring (CGM) transmitter, has a switch disconnect circuit that reduces battery discharge while the device is stored and/or in "shelf mode." The device has two externally-accessible activation pads each configured to contact a same electrical conductor positioned in packaging for the device that causes t...